INTRODUCTION
============

Antibiotics have to penetrate the outer membrane to enter Gram-negative bacteria. One possible pathway is the diffusion through the lipid phase ([@bib32]), especially for the hydrophobic first-generation quinolones ([@bib9]). However, the outer membrane also contains a plethora of channel-forming proteins called porins. Recent studies on multidrug resistance revealed modified porin patterns in the outer membrane. Resistant cells were found to reduce the number, to show mutated porins, or to express different porins ([@bib30]). These findings suggested that a reduced permeation through porins is one possible contribution to drug resistance and motivated studies on interactions between antibiotics and porins ([@bib20]; [@bib41]).

Here, the major outer membrane protein F (OmpF) isolated from *Escherichia coli* is in the focus ([@bib29]) because it is suggested that newer, more hydrophilic quinolones like enrofloxacin use OmpF as an entrance to the cell interior ([@bib9]). OmpF forms a homotrimer, and each monomer forms a channel (pore) consisting of a 16-stranded antiparallel β-barrel ([@bib7]). At the periplasmic side, the β-strands are connected by short turns, and at the extracellular side they are connected by long loops. Loop 3 (L3) is folded back into the pore and constricts its size ([@bib7]). Molecules smaller than ∼600 D can pass the pore such as ions, carbohydrates, amino acids ([@bib29]; [@bib9]), and small antibiotic molecules ([@bib27]).

Antibiotics interact with affinity sites in the pores of OmpF, thus transiently blocking the pathway and causing fluctuations of the measured ionic current. Molecular dynamic (MD) simulations ([@bib24]) have shown that each monomeric pore of OmpF has two binding sites for enrofloxacin called Mini Above at the external side of the constriction zone formed by L3 and Mini Below at the periplasmic side (see [Fig. 5](#fig5){ref-type="fig"}). Enrofloxacin is a fluoroquinolone and inhibits the activity of bacterial DNA gyrase ([@bib22]). In the case of enrofloxacin ([@bib24]) or HPA3P, an analogue of the antimicrobial peptide HP(2--20) ([@bib2]), the residence time at the OmpF binding site is in the millisecond range, leading to clear transitions between the current levels in the open and in the blocked state. In contrast, most other antibiotics bind very weakly to OmpF or OmpC. This leads to residence times in the range of 100 to 200 µs. In the case of weak binding, blocking by the antibiotic is indicated by short spikes, increased noise, or reduction of the apparent ionic current ([@bib25]). In that case, unphysiologically high concentrations of the antibiotics can be used to increase the number of transitions into the blocked state and thus to make them more obvious.

Here, we demonstrate that the information about a fast blocking process can also be obtained at concentrations of the antibiotic below 1 mM if the noisy time series of the ionic current is analyzed by β distributions. We have investigated the fast-flickering binding of enrofloxacin to OmpF which occurs in the presence of Mg^2+^. Mg^2+^ itself has only a small influence on ionic current. In our experiments, addition of 5 mM MgCl~2~ resulted in an increase of current of ∼10%, as expected from the increase in conductivity of the medium (unpublished data). The presence of Mg^2+^ has been selected for several reasons: first, the plasma concentration of Mg^2+^ in humans is 0.4 to 0.8 mM ([@bib42]). The concentration here (5 mM) is higher than that in the plasma, but this concentration has been chosen to make the effects more obvious for a biophysical analysis. Second, in the presence of Mg^2+^, the crystal structure of OmpF shows an additional electron density arising from a (H~2~O)~6~-coordinated Mg^2+^ ion near D113, L115, and E117 in the L3 loop ([@bib44]) which overlaps with the periplasmic binding domain Mini Below for enrofloxacin comprising M114, L115, and P116 on the L3 loop and Q262, R270 on the pore wall ([@bib24]). Mg^2+^ has been found nowhere else in the structure. If we assume that these findings of crystal structure analysis also apply to electrophysiological experiments, the presence of Mg^2+^ can help to discriminate between the periplasmic and the external binding site and reveal further details of the periplasmic site. Third, this region on L3 is of special interest as the removal of the negative charge by the point mutation D113N reduces the strong binding of enrofloxacin to OmpF, leading to shorter residence times in the range of 100 µs ([@bib24]). Fourth, the interpretation of the results can benefit from the knowledge of the crystal structure of OmpF obtained at 1.6-Å resolution ([@bib44]). Together with the MD simulations of [@bib24], this structure provides a molecular background for the interpretation of the electrophysiological results.

The experimental access for studying these binding phenomena is provided by the blocking-induced modulation of the ion current through the three pores of the trimeric porin. In contrast to the previously analyzed slow block in the absence of Mg^2+^ ([@bib24]), the flickery block in the presence of Mg^2+^ consists of blocking events shorter than the temporal resolution of the recording apparatus (5-kHz 4-pole Bessel filter). Thus, they cannot be observed as transitions between states of high and low conductivity in the time series of single-porin current but only as increased noise of the high-conductance state. The clue for the analysis of fast blocking processes is provided by this increase in open-pore noise and a reduction of the apparent open-pore current. The excess noise is evaluated by fitting the broadened and often non-Gaussian amplitude histograms by means of so-called β distributions ([@bib11]; [@bib45]; [@bib40]; [@bib18]; [@bib43]; [@bib35], [@bib38],[@bib39]; [@bib1]). In this analysis, the unavoidable low-pass filter of the recording set-up is not viewed as a nasty obstacle but as a part of the evaluation process as it converts short open times into current values ([@bib15]). The method yields the rate constants of the open-blocked transitions and the true single-pore current.

MATERIALS AND METHODS
=====================

OmpF was purified from *E. coli* by H. Weingart (Jacobs University, Bremen) with the final solution containing 1 mg/ml in 1% Octyl-(polydisperse)oligooxyethylene (Octyl-POE; [@bib13]). Enrofloxacin (Fluka Analytical) was dissolved in 100 mM KCl, 5 mM MgCl~2~, and 5 mM HEPES, pH 7.0, to a concentration of 2 mM. This stock solution was added to the experimental buffer solution in appropriate amounts to create final concentrations of 0.1, 0.3, or 0.4 mM enrofloxacin.

The experimental set-up
-----------------------

The bilayer experiments were performed by the so-called solvent-free method ([@bib26]). In brief, two Teflon chambers were sealed together by silicone and separated by a 25-µm-thick Teflon foil (Goodfellow). The Teflon foil contained a 60--120-µm circular aperture and was pretreated with 1% hexadecane in hexane. After the hexane had evaporated, the chambers were filled with 2 ml buffer (100 mM KCl, 5 mM MgCl~2~, 5 mM HEPES, pH 7). In this study, we used symmetric lipid membranes consisting of uncharged diphytanoylphosphatidylcholine (DPhPC; Avanti Polar Lipids, Inc.) as well as asymmetric membranes containing negatively charged lipopolysaccharides (LPSs) on the trans side, and on the cis side a mixture of phosphatidylethanolamine (PE) from *E. coli*, phosphatidylglycerol (PG) from *E. coli*, and cardiolipin (diphosphatidylglycerol, DPG), with the ratio PE/PG/DPG being 81:17:2. LPS was extracted from the *E. coli* strain WBB01 by the phenol/chloroform/petroleum ether method ([@bib12]), purified, and afterward lyophilized at the Research Center Borstel. The concentration of LPS dissolved in chloroform/methanol (9:1; Merck) was 2.5 mg/ml Lipids (Avanti Polar Lipids, Inc.) were dissolved in chloroform (2.5 mg/ml).

10 µl of the phospholipid solutions was added to the buffer surfaces on each side of the chamber. For asymmetric membranes, LPS was added only at the trans side. After the organic solvent had evaporated, the membrane could be formed by lowering and raising the buffer levels. For OmpF insertion, \<1 µl of a stock solution of 1 mg/ml was diluted by a factor of at least 100,000. Starting with a minimum amount of 0.1 µl of the diluted solution, OmpF was always added on the cis (ground) side until the electrical activity of one porin could be observed. In the case of the asymmetric membranes, the cis (uncharged) side is the side from where OmpF also enters the bacterial membrane. We found that it did not insert from the LPS side. The time intervals between the additions were at least 3 min.

Single-trimeric porin currents were measured by an Axopatch 200B amplifier (Molecular Devices) connected to Ag/AgCl electrodes (World Precision Instruments). The electrode on the trans side was connected to the amplifier. The cis side was connected to ground. The signal was filtered by a 5-kHz four-pole low-pass Bessel filter and sampled at 50 kHz using a Digidata 1322A digitizer and pClamp 10.0 software (Molecular Devices). All measurements were performed at 37°C. During the experiments water evaporation was negligible as measured by conductance.

Determination of the noise
--------------------------

The knowledge of the rms of the baseline noise (*σ*) is crucial for the analysis. However, because of the extremely high open probability of OmpF, the baseline was never visible. Instead, the noise of the Gaussian distribution of time series measured at the same bilayer either at the same voltage without enrofloxacin or at negative potentials with enrofloxacin on the cis side was used. The absence of contributions from blocking-induced noise in these records was verified by the finding that all three observable levels, *I~1~*,*I~2~*, and *I~3~*, could be fitted with Gaussian distributions of equal width (see [Fig. 6 A](#fig6){ref-type="fig"}). This baseline noise was σ = 2.1 pA ± 0.2 pA (*n* = 47) and was determined for each individual dataset.

Analysis: fitting amplitude histograms
--------------------------------------

When individual blocking or gating events can no longer be resolved in a time series, the amplitude histograms can be evaluated. They are fitted by means of β distributions as has been described in previous papers ([@bib35], [@bib36], [@bib37], [@bib38],[@bib39]). The method applies when open-point histograms show broadening with respect to the baseline noise and/or are non-Gaussian (see [Figs. 4](#fig4){ref-type="fig"}, [6](#fig6){ref-type="fig"}, and [7](#fig7){ref-type="fig"}). Both phenomena indicate unresolved fast blocking or gating events. In brief, before starting the fit, the program *KielPatch* was used to extract the partial amplitude histogram of the largest open-level current (*I~3~*) from time series of 4--60-s length (i.e., 200,000 to 3,000,000 sampling points). This so-called open-point histogram included fast flickering events and excluded the (rare) slow events ([@bib34]).

For the analysis, a theoretical amplitude histogram had to be fitted to the measured amplitude histogram. The theoretical amplitude histogram was generated from a time series of flickering current by simulations on the basis of three identical copies of a two-state Markov model (see [Eq. 1](#fd1){ref-type="disp-formula"} and [Fig. 1 C](#fig1){ref-type="fig"}) and afterward convoluted with a Gaussian distribution representing baseline noise of adequate width (i.e., with the σ determined as described in the previous section). During the fit, the rate constants of the Markov model for the simulated time series were modified under the control of a simplex algorithm ([@bib6]) in the laboratory-made program *bownhill*, whereas the current levels (*I~true~* and *I~B~*, [Fig. 1 C](#fig1){ref-type="fig"}) were iteratively suggested in a dialog until a minimum error was found (see [Fig. 7 C](#fig7){ref-type="fig"}). Simulations had to be used for the generation of the theoretical histograms because there is no simple analytical approach for the calculation of β-distributions of higher order Bessel filters ([@bib33]). Shot noise resulting from the discrete nature of the electrical charge could be ignored ([@bib39]). The programs *KielPatch* and *bownhill* are available at <http://www.zbm.uni-kiel.de/aghansen/software.html>.

![Definitions of current components used in data analysis. (A) Contribution of the constant (*I~B~*) and flickering components (*I~app~*) of each pore to the measured single-porin current. (B) Illustration of the levels *I~0~* to *I~3~* observable in a measured time series. (C) Scenario used for fitting amplitude histograms. *I~p~* is the sum of *I~B~* and the true (reconstructed by fitting) single-pore current *I~true~*.](JGP_201210776_Fig1){#fig1}

Analysis: definition of currents
--------------------------------

The study of transport of enrofloxacin here is more difficult than in the case of canonical ion transport. Because the primary transportee (the antibiotic) is zwitterionic under the conditions here ([@bib22]), it does not contribute to electrical current. Instead, the measured current is carried by smaller ions, and transport of enrofloxacin has to be estimated from the modulation of this current as caused by the binding of enrofloxacin to the pore ([@bib24]). Here, we concentrate on the binding kinetics of enrofloxacin as obtained from the measured current and not on the net transport of the antibiotic.

Modeling the flickering currents in OmpF is also different from that of gating in ion channels (e.g., in the BK channel; [@bib36], [@bib37]) in two other aspects. First, as a result of the trimeric nature of OmpF, the theoretical curves are generated from a superposition of three identical models of fast flickering single-pore current. All models had the same rate constants and current levels ([Fig. 1 C](#fig1){ref-type="fig"}). Second, in each pore there is one state of high conductivity (O, open = unblocked) and one state of low conductivity (B, blocked), which turns out not to be zero in the analysis described in the Results section entitled Enrofloxacin blocks only 3/4 of the ionic current in the case of fast blocking. Thus, the canonical symbol C (closed) as used for modeling of ion channels is replaced by B (blocked). Because of this, single-pore current consists of two components: the constant current *I~B~* of the blocked state and a flickering component *I~app~*, ([Fig. 1 A](#fig1){ref-type="fig"}). In the measured time series, the constant components of the three pores cannot be distinguished. Thus, the lowest level observable in the presence of enrofloxacin is *I~0~* = 3 *I~B~* ([Fig. 1 B](#fig1){ref-type="fig"}). In the flickering part of the porin current, a superposition of the three currents *I~app~* can lead to four observable levels: *I~0~*, *I~1~*, *I~2~*, and *I~3~*, depending on the number of pores in the open state ([Fig. 1 B](#fig1){ref-type="fig"}). In the experiments here, the open probability is so high that mostly *I~3~* and rarely *I~2~* can be observed ([Fig. 2](#fig2){ref-type="fig"}). The flickering component is called *I~app~* (apparent) because its original (true) value, *I~true~*, is attenuated because the unavoidable low-pass filter of the set-up averages over the current values in the open and blocked state.

The determination of *I~app~* needs some comments. The amplitude histogram obtained from flickering time series (as in [Fig. 2](#fig2){ref-type="fig"}) normally is not Gaussian. Thus, the peak of the distribution is quite different from what the experimenter would intuitively consider the middle of the broad noisy current level. Furthermore, this value strongly depends on the low-pass filter of the set-up. *I~app~* reaches an asymptotic constant value, when the filter frequency is low enough ([@bib37]). Thus, it is determined here from the peak of the nearly Gaussian distribution obtained after averaging \>200 sampling points.

![Representative sections of current traces of a single OmpF porin recorded at −100 mV (A--D) and +100 mV (E--H) measured in an asymmetrical LPS membrane. Traces were obtained without antibiotic (A and E), with 0.1 mM (B and F) and 0.3 mM enrofloxacin (C and G) on the trans side and 0.3 mM enrofloxacin on the cis side (D and H). The level of full current (all three pores open) is not affected in the presence of enrofloxacin at negative potentials (B--D), regardless of whether it is applied at the trans (B and C) or cis (D) side. At +100 mV, enrofloxacin causes apparent current reduction and a strong increase in noise which is smaller when given at the cis side (H) than at the trans side (F and G). Enrofloxacin given at the cis side at −100 mV causes pronounced slow blocking events (D). All measurements of this and the following graphs were performed at 37°C.](JGP_201210776_Fig2){#fig2}

For the understanding of the biophysics of the process, the true flickering current *I~true~* ([Fig. 1 C](#fig1){ref-type="fig"}) is relevant. *I~tru~*~e~ could be observed directly if the temporal resolution were high enough (for a proper definition of *I~true~* see [@bib16]). Increasing temporal resolution has succeeded in the case of the Cs^+^ block in *Chara* ([@bib10]), but here flickering is too fast and has to be evaluated by means of β distributions.

RESULTS
=======

Induction of fast blocking events (ion current flickering) in the single-porin current by enrofloxacin in the presence of Mg^2+^
--------------------------------------------------------------------------------------------------------------------------------

[Fig. 2](#fig2){ref-type="fig"} shows time series of single-porin ion current measured in an LPS membrane at −100 mV and +100 mV with no antibiotic or with enrofloxacin given at the trans or cis side, respectively. At negative membrane potentials, enrofloxacin has no measurable effect on the current level and on the open-pore noise ([Fig. 2, B--D](#fig2){ref-type="fig"}). Slow blocking events at negative voltages occur only when enrofloxacin is given at the cis side ([Fig. 2 D](#fig2){ref-type="fig"}). The slow block corresponds to the behavior in the absence of Mg^2+^ and has been analyzed previously ([@bib24]). Thus, it is not investigated here in more detail.

The remarkable effect occurs at positive membrane potentials, i.e., the induction of excess open-pore noise in the presence of enrofloxacin. This coincides with a reduction of the apparent open-pore current amplitude ([Fig. 2, F--H as compared with E](#fig2){ref-type="fig"}). The effect is strongest when enrofloxacin is given on the trans side ([Fig. 2, F and G](#fig2){ref-type="fig"}). When enrofloxacin is given on the cis side the current reduction is less pronounced ([Fig. 2 H](#fig2){ref-type="fig"}). As shown in more detail in [Fig. 8 (A and C)](#fig8){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}, the effect of 0.3 mM cis ([Fig. 3 H](#fig3){ref-type="fig"}) is similar to that of 0.1 mM trans ([Fig. 2 F](#fig2){ref-type="fig"}).

###### 

 Normalized rates (r~OB~ = k~OB~/enrofloxacin concentration) for various transmembrane voltages

  Enrofloxacin concentration/bilayer type   *r~OB~* 1/(mM × ms) at +100 mV   *r~OB~* 1/(mM × ms) at +75 mV   *r~OB~* 1/(mM × ms) at +50 mV
  ----------------------------------------- -------------------------------- ------------------------------- -------------------------------
  0.1 mM trans DPhPC                        164 ± 82 (3)                     78 ± 16 (2)                     38 ± 24 (3)
  0.3 mM trans DPhPC                        119 ± 45 (2)                     88 ± 29 (2)                     37 ± 30 (2)
  0.1 mM trans LPS                          150 ± 33 (4)                     99 ± 35 (2)                     43 ± 5 (2)
  0.3 mM trans LPS                          147 ± 43 (3)                     121 ± 34 (2)                    46 ± 4 (2)
  mean trans                                148 ± 48 (12)                    96 ± 28 (8)                     41 ± 17 (9)
  0.1 mM cis DPhPC                          32 ± 9 (4)                       22 ± 9 (2)                      11 ± 4 (4)
  0.3 mM cis DPhPC                          35 ± 19 (5)                      33 ± 30 (3)                     13 ± 12 (2)
  0.1 mM cis LPS                            48 ± 16 (5)                      37 ± 16 (2)                     10 ± 4 (4)
  0.3 mM cis LPS                            54 ± 16 (5)                      38 ± 17 (2)                     11 ± 4 (4)
  mean cis                                  46 ± 25 (19)                     32 ± 19 (9)                     11 ± 5 (14)

The same data is shown as in [Fig. 8 (A and C)](#fig8){ref-type="fig"}. In parentheses: number of experiments.

The scenario (type F+ = flickering at positive membrane potentials) shown in [Fig. 2](#fig2){ref-type="fig"} was found in 10 out of 11 OmpFs inserted in LPS membranes and in 6 out of 9 OmpFs inserted in DPhPC membranes. The other type (F− = flickering at negative potentials) showed the same behavior as the F+ type when membrane potential was inverted and cis and trans were exchanged. From this finding, we concluded that OmpF can insert in different orientations into the membrane but that the F+ type is preferred, especially in asymmetric LPS membranes. We exploited this asymmetric occurrence of flickering (and a concomitant slight asymmetry in the IV curves without enrofloxacin, see means obtained from [Fig. 3](#fig3){ref-type="fig"}) to ensure that all channels investigated here have a single (F+ type) orientation.

In [Fig. 3](#fig3){ref-type="fig"}, the IV curves of the F+ type are shown for the apparent current *I~app~* in LPS and DPhPC membranes with *I~app~* being determined as described in Materials and methods. As a result of the high open probability of OmpF, they present the current at level 3 (*I~3~*, all three pores open). There is no difference in the conductivity of the two different membrane types in the absence of enrofloxacin. The IV curves in the absence of the antibiotic are almost linear (black symbols in [Fig. 3](#fig3){ref-type="fig"}) with the current at −100 mV being ∼15% smaller (*I~3~* = −88.0 ± 3.4 pA, *n* = 3 experiments in DPhPC, and −88.2 ± 5.4 pA, *n* = 8 in LPS) than compared with that at +100 mV (*I~3~* = 102.4 ± 0.8 pA, *n* = 3 in DPhPC, and 101.5 ± 5.0 pA, *n* = 8 in LPS). This results in a first estimate of apparent single-pore currents (*I~3~*/3 = 1/3 single-porin current) of −29.4 pA and 34 pA for −100 mV and +100 mV, respectively. However, these values have to be further analyzed in terms of the definitions given in [Fig. 1](#fig1){ref-type="fig"}. The interpolated values between −50 mV and +50 mV have been verified by voltage ramp protocols (unpublished data).

In the presence of enrofloxacin, the IV curves of the F+ type become sublinear at positive potentials according to the decrease in current as found in [Fig. 2 (F--H)](#fig2){ref-type="fig"}. The effect is more pronounced when enrofloxacin is given at the trans side ([Fig. 3 A](#fig3){ref-type="fig"}) as compared with the cis side ([Fig. 3 B](#fig3){ref-type="fig"}). Furthermore, the effect is slightly stronger in LPS membranes (dashed lines with open symbols) than in DPhPC membranes (solid lines with filled symbols). Even though this difference is hardly greater than the error bars, it gets further support from the kinetic analysis described in the Results section entitled The rate constants of the enrofloxacin-induced fast blocking events. At −100 mV, the current *I~3~* in [Fig. 3](#fig3){ref-type="fig"} is not significantly influenced by the presence of enrofloxacin or by the type of membrane (without: −88.0/−88.2 pA in DPhPC/LPS (*n* = 3/8), 0.3 mM trans: −86.2 ± 4.5 pA (*n* = 2) in DPhPC, −85.9 ± 0.8 pA (*n* = 3) in LPS, 0.3 mM cis: −87.0 ± 4.9 pA (*n* = 2) in DPhPC, and −86.6 ± 7.9 pA (*n* = 5) in LPS).

![IV curves of apparent single-OmpF current *I~3~* (sum of the three monomer currents) in the absence of the antibiotic (black crosses) and with enrofloxacin given at the trans side **(**A) and the cis side (B) at 0.1 mM (red squares) and 0.3 mM (green circles). LPS: open symbols and dashed lines; DPhPC: filled symbols and solid lines. The insets provide an enlarged presentation of the range where the IV curves differ. Data points are shown as mean and standard error, *n* = 2--9 per symbol, with a total of 199 current traces.](JGP_201210776_Fig3){#fig3}

Amplitude histograms of the enrofloxacin-induced flickery block
---------------------------------------------------------------

As mentioned, flickering faster than the corner frequency of the recording set-up leads to averaging over open and blocked events decreasing the amplitude of the recorded signal. The resulting distortions of the open-point amplitude histogram (broadening and skewness) provide the key for revealing the original parameters of this fast process ([@bib15]; [@bib35], [@bib38]). Thus, the analysis by means of β distributions starts from amplitude histograms like those in [Fig. 4](#fig4){ref-type="fig"}, which are created from time series of the F+ type shown in [Fig. 2](#fig2){ref-type="fig"}.

At negative potentials, enrofloxacin added at the trans side has no significant effect on the shape of the amplitude histogram ([Fig. 4 A](#fig4){ref-type="fig"}, left). Furthermore, the levels *I~2~* to *I~0~* are absent, corresponding to [Fig. 2 (A--C)](#fig2){ref-type="fig"}. In contrast, enrofloxacin given at the cis side at negative potentials leads to the appearance of the conductance levels *I~2~* (2 pores open) and, very rarely, *I~1~* (1 pore open) in [Fig. 4 B](#fig4){ref-type="fig"} (left). The events related to evel *I~1~* in [Fig. 4 B](#fig4){ref-type="fig"} are not obvious in the trace of [Fig. 2 D](#fig2){ref-type="fig"} because their occurrence is \<1% of that of *I~3~*. Subtracting three times the difference *I~3~* − *I~2~* from *I~3~* (*I~3~* − 3 *I~app~* in [Fig. 1, A and B](#fig1){ref-type="fig"}) leads to a mean value of *I~0~* = 20.6 ± 8.4 pA (*n* = 4) for 0.3 mM and 20.5 ± 0.7 pA (*n* = 3) for 0.1 mM enrofloxacin on the cis side. This nonzero value of *I~0~* (corresponding to 3 *I~B~* in [Fig. 1 B](#fig1){ref-type="fig"}) indicates that the pores are not closed completely during enrofloxacin-induced blockage. However, the slow block as found at negative potentials ([Fig. 2 D](#fig2){ref-type="fig"}) has already been described by [@bib24] and thus it is not discussed here in detail.

![Amplitude histograms from representative time series of OmpF in an asymmetrical LPS membrane similar to those in [Fig. 2](#fig2){ref-type="fig"} with enrofloxacin given on the trans side (A) and the cis side (B) at −100 mV and +100 mV. Black lines are the controls with zero enrofloxacin, red with 0.1 mM enrofloxacin, and green with 0.3 mM enrofloxacin.](JGP_201210776_Fig4){#fig4}

The interesting effects occur at positive potentials when fast flickering is induced. Corresponding to the noisy records and the apparent reduction of the current level ([Fig. 2, F--H](#fig2){ref-type="fig"}), the amplitude histograms in the presence of enrofloxacin become skewed and broadened ([Fig. 4, A and B](#fig4){ref-type="fig"}, right).

The kinetic model and the orientation of OmpF
---------------------------------------------

As mentioned in Materials and methods, the theoretical amplitude histograms used for fitting have to be created from simulated time series on the basis of an adequate model. A two-state Markov model ([Eq. 1](#fd1){ref-type="disp-formula"}) has been found to be sufficient to adequately fit the open-point histograms of *I~3~* (all three pores open):$${B\ \underset{k_{OB}}{\overset{k_{BO}}{\rightleftharpoons}}\ O}.$$

The definitions of the rate constants are illustrated in [Fig. 5, A and B](#fig5){ref-type="fig"} using two different representations of OmpF. For [Fig. 5 A](#fig5){ref-type="fig"}, the crystal structure of a single pore of the trimeric OmpF has been used ([@bib44]), showing the two binding sites on either side of the constriction zone CR which is formed by the L3 loop (black; [@bib24]). Using PyMOL (DeLano Scientific, version v0.99), the β sheets of OmpF have been made transparent to open the view on the binding sites for (H~2~O)~6~-coordinated Mg^2+^ (yellow: D113, E117; red: L115; [@bib44]) and for enrofloxacin at the periplasmic Mini Below (red: L115; purple: M114, P116 and Q262, R270) and at the external Mini Above (blue: Y32, M38, R82, F118, and R132). The residues D113 to F118 are located on L3.

In the binding domain Mini Above, the negative carboxylic end of enrofloxacin binds to R132 and R82. The antibiotic anchors in hydrophobic pockets at residues M38, F118 and the positive end is at Y32 ([Fig. 4](#fig4){ref-type="fig"} in [@bib24]). In Mini Below, the negative carboxylic end forms hydrogen bonds with R270, Q262, and H-C bonds are formed with M114, P116, and L115 ([Fig. 7](#fig7){ref-type="fig"} in [@bib24]). Important for the investigations here is the overlapping of the binding sites for (H~2~O)~6~--Mg^2+^ and those for enrofloxacin at Mini Below in the range of D113 to E117 on the L3 loop of the constriction zone. In [Fig. 5 B](#fig5){ref-type="fig"}, the structure of OmpF is given as a cartoon highlighting those parts of the OmpF structure, which are important for the discussion of the results reported below.

[Fig. 5 A](#fig5){ref-type="fig"} shows the rate constants of enrofloxacin binding to the periplasmic binding site for the case that enrofloxacin is added at the periplasmic side and [Fig. 5 B](#fig5){ref-type="fig"} for addition at the external side. The electrophysiological studies cannot distinguish between the off-rate constants *k~BO~*~,*t*~, which leads to translocation (t) through the membrane, and *k~BO~*~,*b*~, which brings enrofloxacin back (b) to the solution where it came from. Thus, the analysis in the next section only yields *k~BO~* = *k~OB~*~,*t*~ + *k~OB~*~,*b*~. An approach to calculate the fluxes from these rates constants has been suggested by [@bib24].

![Definition of the rate constants of blocking (*k~OB~*) and unblocking (*k~BO~*) under the assumption that the location of Mg^2+^ as found in crystal structure also applies to the electrophysiological studies here ([@bib44]). The assignment periplasmic = trans results from the most plausible interpretation of the difference in accessibility described in [Figs. 8](#fig8){ref-type="fig"} and [9](#fig9){ref-type="fig"} for the dominant F+ type insertion (flickering at positive potentials). (A) Crystal structure obtained by [@bib44]. (PDB code 2ZFG, the water-coordinated Mg^2+^, and two detergent molecules have been removed for clarity.) Enrofloxacin (yellow bipolar ellipse) is given at the periplasmic side. Here, the issue of coloring the involved residues is showing the association of residues to the binding domains; thus, conventional coloring of amino acids has not been used. The binding domain of the (H~2~O)~6~-coordinated Mg^2+^ ion, including the residues D113, E117 (yellow), and L115 (red), is on the L3 loop (black) of the constriction zone CR. Residues on L3 are also involved in the periplasmic bindings site Mini Below for enrofloxacin (purple and red). The binding site Mini Above (blue) does not play a role in the fast blocking events investigated here. (B) For the definition of the rate constants that are involved when enrofloxacin is given at the external side, a cartoon is used. It highlights those features of the Ompf structure in A which are important for the understanding of the fast flickering events. The blue sphere presents (H~2~O)~6~-Mg^2+^, and the purple ring the binding site Mini Below.](JGP_201210776_Fig5){#fig5}

The orientation of OmpF in artificial bilayer membranes is still under discussion (for references, see the Discussion). Here, the suggestion that trans = periplasmic for the F+ type orientation as presented in [Fig. 5](#fig5){ref-type="fig"} is based on the study of the accessibility of the binding sites. As considered in more detail in the Discussion, the validity of this assignment depends on whether the results from crystal structure analysis ([@bib44]) and MD simulations ([@bib24]) also apply to the electrophysiological data here. However, keeping this caveat in mind we tentatively describe the results on the basis of the model in [Fig. 5](#fig5){ref-type="fig"}. For this model, we have to combine the following findings obtained for the dominant F+ type insertion: (1) Mg^2+^ interferes with Mini Below at the periplasmic side ([Fig. 5 A](#fig5){ref-type="fig"}; [@bib44]); (2) flickering is related to the presence of Mg^2+^ (it is absent in experiments without Mg^2+^, [@bib24]); (3) flickering only occurs at positive membrane potentials ([Fig. 2, F--H](#fig2){ref-type="fig"}); (4) flickering is stronger when enrofloxacin is given at the trans side (compare [Fig. 2, F and G](#fig2){ref-type="fig"} vs. [Fig. 3 H](#fig3){ref-type="fig"}, and see evaluation of [Fig. 8, A and C](#fig8){ref-type="fig"}); and (5) in the presence of Mg^2+^, slow gating only occurs at negative potentials when enrofloxacin is given at the cis side.

Finding 3 yields a plausible suggestion for the orientation of OmpF when enrofloxacin is added on the cis side because orientation by positive potentials is required to pass the constriction zone from the external side (carboxyl group first, MD simulations of [@bib24]; see also [Fig. 10 D](#fig10){ref-type="fig"}). Item 4 leads to the conclusion that the lower binding rate of enrofloxacin from the cis side (details in [Fig. 8, A and C](#fig8){ref-type="fig"}) results from the necessity that enrofloxacin has to pass the constriction zone to reach Mini Below. Item 5 indicates that Mini Above can easily be reached from the cis side at negative potentials but not from the trans side, as it is hindered to pass the constriction as a result of the wrong orientation by the electric field. Collectively, these considerations lead to the assignments shown in [Fig. 5 A](#fig5){ref-type="fig"}, i.e., cis = external and trans = periplasmic in the experiments evaluated here. Nevertheless, the validity of this conclusion depends on the premise that the results of crystal structure analysis ([@bib44]) also apply to the electrophysiological studies here. A more reliable approach based on the accessibility of blockers to adequately located mutations as used by [@bib17] for *KcsA* in bilayers has not succeeded so far for OmpF because the porin lets agents up to 600 D pass the pore ([@bib29]; [@bib9]).

Evaluation of fast gating by β distributions
--------------------------------------------

In [Fig. 6 A](#fig6){ref-type="fig"}, it is shown that the amplitude histograms related to slow blocking (data from [Fig. 4 B](#fig4){ref-type="fig"}, −100 mV, 0.3 mM enrofloxacin at the cis side) can very well be fitted by Gaussian distributions of equal width (this is used for the determination of baseline noise *σ*), whereas such a fit is not possible at positive potentials in the presence of enrofloxacin ([Fig. 6 B](#fig6){ref-type="fig"}, blue dotted curve). However, a fit by a β distribution based on three identical two-state models ([Fig. 1 C](#fig1){ref-type="fig"} and [Eq. 1](#fd1){ref-type="disp-formula"}) is successful ([Fig. 6 B](#fig6){ref-type="fig"}, red solid curve). For all cases, the two-state model of [Eq. 1](#fd1){ref-type="disp-formula"} has been found to be sufficient because analysis with a higher number of states ([@bib38]) has not improved the quality of the fit.

![Examples for fitting of amplitude histograms in the presence of 0.3 mM enrofloxacin on the cis side in an LPS membrane. Data are taken from [Fig. 4 B](#fig4){ref-type="fig"}. (A) Successful fitting of Gaussians (red) to an all-point amplitude histogram with slow blocking measured at −100 mV resulting in *σ~0~* = 2.6 pA and an estimated single-pore current *I~app~* = 20.8 pA. (B) Failure of fitting an open-point histogram measured at +100 mV by a Gaussian distribution (blue dotted line). Successful fitting of the data with a β distribution (red solid line) resulting in *I~true~* = 22.7 pA, *I~B~* = 12 pA, *k~OB~* = 20 700 s^-1^, and *k~BO~* = 67 000 s^-1^ ([Eq. 1](#fd1){ref-type="disp-formula"}, [Figs. 1 C](#fig1){ref-type="fig"} and [5](#fig5){ref-type="fig"}).](JGP_201210776_Fig6){#fig6}

Enrofloxacin blocks only 3/4 of the ionic current in the case of fast blocking
------------------------------------------------------------------------------

Experiments with planar lipid bilayers suffer less from leakage currents as compared with giga seals of patch pipettes. Thus, the analysis of the data with enrofloxacin by means of the scenarios in [Figs. 1](#fig1){ref-type="fig"} and [5](#fig5){ref-type="fig"} yields a surprising result: the simple approach with *I~B~* = 0, i.e., that enrofloxacin blocks the ion flow completely, leads to a failure of the fitting routine ([Fig. 7 A](#fig7){ref-type="fig"}). Instead, it has consistently been found that good fits can be achieved only when the B-O model ([Eq. 1](#fd1){ref-type="disp-formula"}) is forced to switch the conductivity of the pore between ∼25 and 100% of the full conductivity ([Fig. 1 C](#fig1){ref-type="fig"}; and [Fig. 7, B and C](#fig7){ref-type="fig"}). Thus, the current *I~B~* of the blocked state is not zero. Consequently, four parameters have to be determined from the β fits: the rate constants *k~BO~* and *k~OB~*, the current of the blocked state (*I~B~*), and the amplitude (*I~true~*) of the flickering current in the presence of enrofloxacin.

![Illustration of the determination of the amplitude of flickering single-pore current *I~true~* (= the difference between the total current of state O (*I~P~*) and of state B (*I~B~*), *I~true~* = *I~P~* − *I~B~*, see [Fig. 1 C](#fig1){ref-type="fig"}). (A and B) Effect of the choice of single-pore current, *I~true~*, on the quality of the fit with β distributions. Open-point histogram of a time series recorded at +100 mV with 0.3 mM enrofloxacin on the trans side of an LPS membrane similar to that in [Fig. 2 G](#fig2){ref-type="fig"}. (A) Failure of the best fit with *I~B~* = 0, *I~true~* = 34.9 pA, equal to *I~P~* = 1/3 of the total current obtained when all three pores are open in the absence of enrofloxacin ([Fig. 2 E](#fig2){ref-type="fig"}). (B) Successful fit of the same data with *I~B~* = 8.3 pA, *I~true~* = 22.8 pA, *k~OB~* = 45,600 s^−1^, and *k~BO~* = 46,950 s^−1^. (C) Dependence of the error sum on the value of the single-pore current *I~true~* used in the fitting routine (for another example in LPS than in B). The optimum value obtained from the best fit is at *I~true~*~,*opt*~ = 19 pA, *I~B~* = 8.4 pA. *I~p~* = 33.5 pA marks the value obtained from records in the absence of enrofloxacin. Data from a single experiment at +100 mV with 0.3 mM enrofloxacin on the trans side. (D) IV curves of *I~B~* and *I~true~* obtained from β fits. The dotted lines present linear fits. The sum *I~P~* = *I~true~* + *I~B~* should theoretically coincide with *I~3woE~*/3 ([Fig. 1 C](#fig1){ref-type="fig"}) of the control measurements without enrofloxacin (*I~3woE~*/3 in DPhPC: solid line; LPS: dotted line, obtained from averaging over data like those in [Fig. 3](#fig3){ref-type="fig"}). Assignment of the symbols: open for LPS membranes, closed for DPhPC membranes. Black squares: 0.1 mM enrofloxacin on the trans side; red circles: 0.3 mM trans; green triangles: 0.1 mM cis; blue diamonds: 0.3 cis. The same symbols are used for *I~B~*, *I~true~*, and the sum *I~P~*. There is no significant influence of the concentration, side of addition, or membrane composition on *I~B~* and *I~true~*; all symbols overlap. Shown are two to five experiments per point with a total of 79 experiments. Error bars represent standard deviation.](JGP_201210776_Fig7){#fig7}

The values of *I~B~* and *I~true~* are shown in [Fig. 7 D](#fig7){ref-type="fig"}. The individual data points present averages over measurements with enrofloxacin given at the cis and trans side at concentrations from 0.1 to 0.3 mM. The symbols for the individual conditions (type of membrane, side of application, concentration of enrofloxacin) can hardly be distinguished in the graph. This is just the message, namely, that *I~B~* and *I~true~* do not significantly depend on these conditions. Averaging over all conditions in [Fig. 7 D](#fig7){ref-type="fig"} by means of the fitted linear lines yields the following conductivities: *g*(*I~B~*) = 84 ± 3 pS and *g*(*I~true~*) = 246 ± 2 pS (error of the fit), which implies that *I~B~* is 25 ± 7% of *I~P~* = *I~B~ + I~true~*, the full current ([Fig. 1 C](#fig1){ref-type="fig"}), with the error being the averaged relative rms over all conditions.

The reliability of the fits is indicated by the fact that the sum of *I~B~ + I~true~ = I~P~* (obtained in the presence of enrofloxacin) perfectly matches the line given by the single-pore current as estimated from dividing level *I~3woE~* in time series without enrofloxacin (woE) by 3. The ratio 3*I~P~/I~3woE~* is 1.00 ± 0.05 as obtained from all 91 records with enrofloxacin.

The rate constants of the enrofloxacin-induced fast blocking events
-------------------------------------------------------------------

The analysis of the fast blocking events ([Figs. 6](#fig6){ref-type="fig"} and [7](#fig7){ref-type="fig"}) induced by enrofloxacin at positive membrane potentials by means of the simple B-O model of [Eq. 1](#fd1){ref-type="disp-formula"} leads to the rate constants of blocking, *k~OB~*, and unblocking, *k~BO~* ([Fig. 5, A and B](#fig5){ref-type="fig"}). For the sake of clarity, the rate constants from LPS and DPhPC membranes are pooled in [Fig. 8](#fig8){ref-type="fig"}. This is legitimate because of the small difference, which becomes obvious from the separate presentations in [Table 1](#tbl1){ref-type="table"} and in [Fig. 9](#fig9){ref-type="fig"}.

The rate constant of unblocking, *k~BO~*, does not significantly depend on the concentration of enrofloxacin ([Fig. 8, B and D](#fig8){ref-type="fig"}) as expected for a dissociation of the antibiotic from the protein. The mean value obtained from averaging over all conditions is *k~BO~* = 99,000 ± 38,000 s^−1^.

![Dependence of the rate constants ([Eq. 1](#fd1){ref-type="disp-formula"}) of fast blocking on the concentration of enrofloxacin given at the trans side (A and B) or cis side (C and D). *k~OB~* (A and C) is the rate constant of blocking (binding of antibiotic) and *k~BO~* (B and D) of unblocking (dissociation of the antibiotic from the protein). Black squares: +50 mV; red circles: +75 mV; green upright triangles: +85 mV; blue inverted triangles: +100 mV. Dashed lines in A and C are linear fits through the origin. For the sake of clarity, the datasets from LPS and DPhPC membranes were pooled, and the symbols show mean and standard error. A separate presentation for both membrane types is given in [Fig. 9](#fig9){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}, where the number of experiments is also given.](JGP_201210776_Fig8){#fig8}

The rate constant of blocking (i.e., binding), *k~OB~*, increases with the concentration of enrofloxacin in the investigated range ([Fig. 8, A and C](#fig8){ref-type="fig"}). The concentration dependence of the effect on *k~OB~* is similar when enrofloxacin is given on the cis or trans side. However, there is a remarkable difference: the curves in [Fig. 8 C](#fig8){ref-type="fig"} (cis) only coincide with the corresponding curves in [Fig. 8 A](#fig8){ref-type="fig"} (trans) when the rate constants, *k~OB~*, are multiplied by a factor of 3.2. Thus, enrofloxacin given at the cis side is about threefold less effective than that given at the trans side.

Linearity up to 0.3 mM is indicated by the fact that the data can be fitted by a line through the origin. Furthermore, for all conditions the normalized rate *k~OB~*~,0.1mM~/0.1 mM, is about equal to *k~OB~*~,0.3mM~/0.3 mM, for all membrane potentials within the scatter ([Table 1](#tbl1){ref-type="table"}). This constant ratio (as well as the linear fit through zero by the dotted lines in [Fig. 8](#fig8){ref-type="fig"}) verifies a linear relationship between blocking rate constant *k~OB~* and enrofloxacin concentration up to 0.3 mM. The ratios are not significantly different for LPS and DPhPC. It remains to be elucidated whether the single data point at 0.4 mM enrofloxacin in [Fig. 8](#fig8){ref-type="fig"} indicates the beginning of saturation.

To provide more information for the discussion of the voltage dependencies of *k~OB~* and *k~BO~*, the same data in [Fig. 8](#fig8){ref-type="fig"} is presented separately for LPS and DPhPC in [Fig. 9](#fig9){ref-type="fig"}. In the case of *k~OB~*, there is a clear voltage dependence, but no significant difference between LPS and DPhPC.

In contrast to *k~OB~*, the rate constant *k~BO~* of unblocking seems to be quite independent of the enrofloxacin concentration and of the side of the application. There seems to be a slight dependence on membrane potential. Even though the scatter per data point is high, the parallel behavior of eight curves is convincing. Interestingly, the clouds of values obtained from LPS (dotted lines with open symbols in [Fig. 9 B](#fig9){ref-type="fig"}) and DPhPC (solid line in [Fig. 9 B](#fig9){ref-type="fig"}) are clearly separated. As a result of the parallel shift of the curves, the difference can be presented by a mean value for all concentrations and potentials: *k~BO~*~,*DPhPC*~ = 115,000 ± 42,000 (*n* = 55), *k~BO~*~,*LPS*~ = 76,000 ± 18,000 (*n* = 42).

![Voltage dependence of the rate constants of blocking (A, *k~OB~*) and unblocking (B, *k~BO~*) of the enrofloxacin-induced fast block (same set of experiments as in [Fig. 8](#fig8){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}). Open symbols and dashed lines present data from LPS, and closed symbols and solid lines those from DPhPC. Red circles: 0.3 mM enrofloxacin trans; black squares: 0.1 mM trans; green diamonds: 0.3 mM cis; blue triangles: 0.1 mM cis. Symbols show mean and standard error, and the number of experiments is given in [Table 1](#tbl1){ref-type="table"}.](JGP_201210776_Fig9){#fig9}

DISCUSSION
==========

The investigations here show that the analysis by β distributions has the power of resolving residence times of ∼10 µs (*k~BO~* up to 120 ms^−1^ in [Figs. 8](#fig8){ref-type="fig"} and [9](#fig9){ref-type="fig"}). This is a factor of 20 above the corner frequency of the experimental set-up and indicates that β distributions are an adequate means of resolving fast blocking events in porins. The necessity of such a gain in temporal resolution becomes obvious, for example, from the study of temperature dependence of ampicillin binding to OmpF ([@bib23]). At higher temperatures, the rate constants could not directly be evaluated because of the limited temporal resolution of classical analytical approaches.

The temporal resolution of 10 µs can be further improved. In patch clamp experiments on BK channels, 0.1 µs could be reached by virtue of the lower noise of excised patches ([@bib36], [@bib38]). With respect to noise, experiments in bilayers suffer from the wider membrane area and the resulting higher membrane capacitance. However, by virtue of the high single-pore current sometimes reaching 100 pA ([@bib5]), the temporal resolution may be even higher than that reached in BK channels when OmpF is expressed in cells, and patch clamping is used.

Nevertheless, the temporal resolution here is obviously sufficient for a complete evaluation of the kinetics of enrofloxacin binding in the presence of Mg^2+^ and leads to several findings which are listed.

(1) *Polarity*
--------------

[Fig. 10](#fig10){ref-type="fig"} illustrates the dependency of the induction of slow and fast blocking events on the polarity of membrane potential and on the side of enrofloxacin addition. The finding that membrane potential has to be positive on the trans side to induce fast flickering and that negative potential does not induce a similar effect when enrofloxacin is given on the cis side is in contrast to the canonical blocking effects in ion channels like BK, where fast flickering is induced when the charged blocking ion (e.g., Tl^+^, [@bib37]; Cs^+^, [@bib10]) is pulled into the channel by the membrane potential. Our favorite hypothesis is based on the fact that enrofloxacin is zwitterionic under the experimental conditions used here ([@bib22]). This suggests a need to orient the molecule before binding as illustrated in [Fig. 10](#fig10){ref-type="fig"}.

![Schematic presentation of the effect of voltage (A and C: −; B and D: + at the trans side) and of the side of enrofloxacin addition (A and B: trans; C and D: cis) on the accessibility of the binding site Mini Below (purple in [Fig. 5](#fig5){ref-type="fig"}) for enrofloxacin. The blue sphere indicates the presence of (H~2~O)~6~-Mg^2+^. The cartoons are made for the dominant F+ type insertions (flickering at positive potentials) under the assumption that the location of Mg^2+^ found in crystal structure analysis ([@bib44]) also applies to the electrophysiological studies used here.](JGP_201210776_Fig10){#fig10}

An alternative hypothesis may be based on the assumption that the positive membrane potential is required to induce an adequate conformational change of the protein for fast flickering binding. Voltage-induced conformational changes have been discussed by [@bib29] starting from the observation that porins spontaneously close at high voltage, typically +100 mV or more (also shown in [Fig. 2 E](#fig2){ref-type="fig"}).

One suggestion is that transmembrane voltages make the channel narrower by bringing the cationic and anionic amino acid side chains closer to each other. However, the spontaneous closures still occur when the loop is fixed to the barrel wall by a disulfide bond ([@bib31]; [@bib4]). Alternatively, an atomic force microscopy study has shown that the application of voltage causes the movement of external loops, resulting in the closure of channel entrance ([@bib28]). [@bib29] also considers a third mechanism, which has been found in the α-toxin of *Staphylococcus aureus*, which is an empty 14-member β-barrel with no constrictions or infolding loops. It shows gating behavior in planar bilayers ([@bib3]), presumably as a result of the fluctuation in the ionization of the charged groups either within or near the channel as also known from holes in a plastic film (polyethylene terephthalate, [@bib21]).

In the case of the experiments here, there are two indications that voltage-induced conformational changes may exist. First, the traces in [Fig. 2 (A and E)](#fig2){ref-type="fig"} and the black amplitude histograms in [Fig. 4 B](#fig4){ref-type="fig"} show that positive voltages lead to the appearance of a current level below *I~2~* in the absence of enrofloxacin, whereas negative voltages do not. These slow transitions occur with *I~B~* = 0, indicating that a different mechanism is involved than that related to the blockage by enrofloxacin. (*I~B~* = 0 becomes obvious in the location of the black peak in [Fig. 4 B](#fig4){ref-type="fig"}, but a detailed analysis will be given in a separate paper dealing with the slow transients). The second indication is related to item 2.

(2) Voltage dependence *of k~BO~*
---------------------------------

In [Fig. 9 B](#fig9){ref-type="fig"}, there is a slight voltage dependence of the rate constant of unblocking (*k~BO~*). The effect is small, and nearly hidden by the scatter. However, the parallel behavior obtained under eight different conditions is intriguing. This may be a consequence of voltage-induced conformational changes mentioned in finding 1, especially as it occurs at potentials where the spontaneous slow transients have been observed. However, a major effect of surface charges can be excluded because the LPS and DPhPC curves are parallel in [Fig. 9 B](#fig9){ref-type="fig"}. Indications of a similar effect on *k~off~* (corresponding to *k~BO~*) have also been found for the dissociation of OmpF and an analogue of the HP(2*--*20) antimicrobial peptide ([@bib2]). This effect may imply that the geometry of the pore is modified by the electric field (as discussed in finding 1). Alternatively, it may be assumed that the electric field exerts a force on the bound agent, especially as it cannot be excluded that the environment at the binding site may shift the distribution of zwitterionic and charged forms of enrofloxacin ([@bib22]).

(3) Voltage dependence of k~OB~
-------------------------------

The rate constant of enrofloxacin binding strongly increases with positive voltage ([Fig. 8, A and B](#fig8){ref-type="fig"}). Here again, the putative mechanisms already mentioned in finding 1 can be involved. Nevertheless, our favorite hypothesis is that the main effect of voltage is mediated by the orientation of enrofloxacin. Then, this voltage dependence would reflect the mean number of adequately oriented approaches to the binding site. However, the voltage-induced effects on slow transients ([Fig. 4](#fig4){ref-type="fig"}, black curves) in the absence of enrofloxacin and on *k~BO~* of fast flickering in [Fig. 9 B](#fig9){ref-type="fig"} may also indicate a direct effect of voltage on the conformation and dynamics of the protein, thus contributing to the strong voltage-dependence of *k~OB~* in [Fig. 9 A](#fig9){ref-type="fig"}. A major role of surface charges ([@bib14]) on the steepness of the voltage dependence can be excluded as there is no significant difference between negatively charged LPS and uncharged DPhPC membranes in [Fig. 9 A](#fig9){ref-type="fig"}.

One effect that also has to be considered is the putative inhomogeneity of the electric field in the pore, as caused by charged residues ([Fig. 5 A](#fig5){ref-type="fig"}). This makes the movement of dipoles sensitive to the field. Evaluating this kind of effect, however, is beyond the reach of this study.

Conclusion for findings 1--3
----------------------------

There is a great variety of possible mechanisms that may be involved in the voltage dependence of enrofloxacin-induced flickering, but there is no unequivocal preference for one of these mechanisms. Nevertheless, considering that a transmembrane field of course leads to an orientation of the zwitterionic antibiotic, and that MD simulations ([@bib24]) have shown that enrofloxacin has to be oriented to pass through the constriction zone, we favor the hypothesis that orientation by the positive potential is a salient factor to explain the scenarios in [Fig. 10 (B and D)](#fig10){ref-type="fig"}.

(4) Concentration dependence
----------------------------

It is not surprising that *k~OB~* increases linearly with the concentration of the antibiotic ([Fig. 8, A and C](#fig8){ref-type="fig"}; [Table 1](#tbl1){ref-type="table"}) because the included message is a priori expected, i.e., that the reaction between OmpF and the antibiotic is bimolecular. The same holds for the apparent independence of *k~BO~* on concentration ([Fig. 8, B and D](#fig8){ref-type="fig"}).

(5) Incomplete block
--------------------

An interesting finding is the incomplete occlusion of the pore by enrofloxacin as indicated by the remaining current *I~B~* of the blocked state ([Fig. 7](#fig7){ref-type="fig"}). This is of special interest, as MD simulations suggested a space of ∼5 Å^2^ accessible to ions at Mini Above and Mini Below when enrofloxacin was bound ([@bib24]).

(6) Effect of Mg^2+^
--------------------

The charge reversion by Mg^2+^ in the region D113 to E117 on the L3 loop ([Fig. 5 A](#fig5){ref-type="fig"}) results in rate constants that are even faster than in the D113N mutant ([@bib24]). The weakening of binding in the presence of Mg^2+^ has also been found for the interaction of OmpF and an analogue of the HP(2*--*20) antimicrobial peptide ([@bib2]). Furthermore, [@bib44] also found an interaction of Mg^2+^ and the unfolded N-terminal domain (T83) of the bacteriocin colicin E3, which is also translocated through OmpF. 1 M Mg^2+^ led to a complete suppression of colicin binding in OmpF crystals.

(7) Sidedness for slow and fast blocking effects
------------------------------------------------

At negative membrane potentials ([Fig. 10, A and C](#fig10){ref-type="fig"}), enrofloxacin causes slow blocking when given at the cis side ([Figs. 2 D](#fig2){ref-type="fig"} and [10 C](#fig10){ref-type="fig"}) but has no effect when given at the trans side ([Fig. 2, B and C](#fig2){ref-type="fig"}; and [Fig. 10 A](#fig10){ref-type="fig"}). This can be explained under the assumption that for OmpF in the F+ orientation the assignment periplasmic = trans holds (see discussion in the next section, Sidedness of k~OB~). This sidedness in [Fig. 2](#fig2){ref-type="fig"} indicates that enrofloxacin can reach the external binding site Mini Above ([Fig. 5, A and B](#fig5){ref-type="fig"}) from the cis side without having to pass the constriction zone ([Fig. 10 C](#fig10){ref-type="fig"}). According to the crystal structure analysis of [@bib44], there is no Mg^2+^ binding at Mini Above, and thus fast flickering should not be observed. In contrast, the orientation at negative potentials is not only inadequate for binding at the periplasmic site Mini Below but also for enrofloxacin passing the constriction zone to reach Mini Above when given at the trans side. In our experiments, passing the constriction zone is only possible when the positive voltage forces the correct orientation ([Fig. 10 D](#fig10){ref-type="fig"}).

In the case of scenario of [Fig. 10 D](#fig10){ref-type="fig"}, the question may arise why enrofloxacin from the cis side can pass the still existing high affinity binding site Mini Above on its way to Mini Below at the trans side of the constriction zone. There are two possible explanations: first, the binding rate constant *k~OB~*~,*cis*~ is by a factor of approximately three smaller than *k~OB~*~,*trans*~. This may not only result from the necessity to pass through the constriction zone but also from the necessity to escape from being trapped by Mini Above. However, it is unlikely that this is valid in numerical terms. More likely is the second hypothesis; [Fig. 2 D](#fig2){ref-type="fig"} shows that slow gating only occurs at negative potentials and when enrofloxacin is given at the cis side. Thus, consistent with the MD simulations of [@bib24] it may be concluded that enrofloxacin has to be oriented by a negative potential to bind to Mini Above. In that case, it would escape from trapping when oriented by a positive potential as in [Fig. 10 D](#fig10){ref-type="fig"}.

(8) Sidedness of k~OB~
----------------------

According to [Figs. 8](#fig8){ref-type="fig"} and [9](#fig9){ref-type="fig"}, the rate constants of binding, *k~OB~*, are higher when enrofloxacin is given on the trans side ([Fig. 10 B](#fig10){ref-type="fig"}) than on the cis side ([Fig. 10 D](#fig10){ref-type="fig"}). This is consistent with the assumption that the trans side is the periplasmic side because the region D113 to E117 is located at the periplasmic side of the constriction zone ([Fig. 5 A](#fig5){ref-type="fig"}).

(9) Orientation
---------------

[Fig. 5 A](#fig5){ref-type="fig"} is drawn under the assumption that trans = periplasmic. This is plausible because of findings 7 and 8. The slight asymmetries in channel conductance ([Fig. 3](#fig3){ref-type="fig"}) and in the dependence of the kinetics on the side of enrofloxacin addition ([Figs. 2](#fig2){ref-type="fig"}, [4](#fig4){ref-type="fig"}, [8](#fig8){ref-type="fig"}, and [9](#fig9){ref-type="fig"}) allow the distinction between two different modes of the orientation of the porin during reconstitution. As mentioned, 9 out of 11 OmpF had the dominant F+ configuration (flickering at positive membranes) in LPS membranes and 6 out of 9 in DPhPC membranes. The results of the kinetic evaluation of the dominant F+ type (findings 7 and 8) only correspond to those from MD simulations ([@bib24]) and crystal structure analysis ([@bib44]) if the periplasmic side of the protein is assumed to be on the trans side of the membrane. In the native bacteria membrane, the orientation of OmpF has been determined ([@bib19]). However, for reconstituted porins so far only weak hints are available. Inspection of accelerated MD modeling ([@bib24]) suggests that enrofloxacin can enter the porin from either side. Coming from the external side, it penetrates the constriction zone with the carboxylic (negative) end first. This corresponds to the situation in [Fig. 10 D](#fig10){ref-type="fig"} only when cis = external side. This is in contrast to the orientation in the bacterial membrane. However, a similar situation has been found for Maltoporin which is known to insert with the periplasmic side first in vitro. This is opposite to the situation in vivo, and the difference is supposed to originate from the involvement of chaperones in the bacteria ([@bib8]).

However, these conclusions about the orientations of OmpF are only valid if the exclusive location of Mg^2+^ at Mini Below (as determined by crystal structure analysis; [@bib44]) also applies to the electrophysiological studies here. Thus, the orientation periplasmic = trans is very plausible but not proven. We have tried to introduce blocking sites by mutations that are only accessible from one side, similar to the approach of [@bib17] for KcsA in bilayers. However, so far these experiments failed to give a definite answer. In OmpF, the situation is less favorable than in ion channels because of the wide diameter of the OmpF pore which allows putative blockers up to 600 D to pass the constriction zone ([@bib29]; [@bib9]). This impedes the concept of accessibility. Nevertheless, this evaluation is at least a stimulus to verify the results from crystal structure analysis by mutational studies influencing Mg^2+^ binding.
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